Brooklyn Investment Group’s TG Therapeutics TGTX Stock Holding History

Brooklyn Investment Group’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$286K	Buy	+8,619	New	+$257K	0.01%	1438
2025 Q3	–	Sell	-507	Closed	-$18.2K	–	2484
2025 Q2	$18.2K	Sell	507 -1,097	-68%	-$40.8K	﹤0.01%	1867
2025 Q1	$63.2K	Buy	1,604 +1,533	+2,159%	+$51.6K	0.01%	685
2024 Q4	$2.14K	Buy	+71	New	+$2.04K	﹤0.01%	1440

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brooklyn Investment Group's TGTX Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in TG Therapeutics (TGTX) in Q1 2026: 8,619 shares worth $286K. The stake represents 0.01% of the portfolio and ranks #1438 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in TGTX as recently as Q2 2025.

Brooklyn Investment Group first reported a position in TGTX in Q4 2024 and has held it in 4 quarters since. 364 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

Brooklyn Investment Group held 8,619 shares of TG Therapeutics worth $286K as of Q1 2026.
TG Therapeutics was a new Brooklyn Investment Group position in Q1 2026.
TG Therapeutics made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1438 holding.
Brooklyn Investment Group first reported a position in TG Therapeutics in Q4 2024 and has held it in 4 quarters since.
364 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.